Columbus, OH, United States of America

Benjamin Markovitz

This inventor holds 2 USPTO granted patents. Top assignees: Myrexis, Inc., Myriad Pharmaceuticals, Inc.. Active years: 2009-2013.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Benjamin Markovitz. Retrieved from https://idiyas.com/inventor/benjamin-markovitz

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 100.0

Average Co-Inventor Count = 9.0

ph-index = 1

Forward Citations = 11(Granted Patents)


Location History:

  • Salt Lake City, UT (US) (2009)
  • Columbus, OH (US) (2013)

Company Filing History:


Years Active: 2009-2013

Loading Chart...
2 patents (USPTO):Explore Patents

Title: The Innovative Contributions of Inventor Benjamin Markovitz

Introduction: Benjamin Markovitz, a notable inventor based in Columbus, Ohio, has made significant strides in the field of cancer treatment through his innovative research. With two patents to his name, Markovitz has focused on developing therapeutic compounds that have the potential to improve patient outcomes in cancer therapy.

Latest Patents: Markovitz's most recent patents include "Purine-core inhibitors of HSP90 and their use in treating cancer" and "Therapeutic compounds and their use in cancer." The first invention details compounds characterized by Formulae I-III, involving various groups such as substituted or unsubstituted aryl, heteroaryl, heterocyclic, or carbocyclic groups. These compounds also incorporate piperidine derivatives and specific substituents like hydro, alkyl, and amino. The second patent similarly explores compounds under Formula I, emphasizing their therapeutic applications and various structural components defined in the specifications.

Career Highlights: Throughout his career, Benjamin Markovitz has held positions at prominent companies including Myriad Pharmaceuticals, Inc. and Myrexis, Inc. His work is characterized by a commitment to advancing medical science and developing innovative solutions for complex health issues, especially in oncology.

Collaborations: Markovitz has collaborated with esteemed colleagues such as Ashok Bajji and Se-Ho Kim. Their joint efforts have contributed to the successful development of his patented inventions, showcasing the power of teamwork in the realm of scientific research and development.

Conclusion: Benjamin Markovitz stands as a significant figure in the landscape of cancer treatment innovations. His patents reflect a deep understanding of complex biochemical interactions and a dedication to improving healthcare outcomes. As he continues to explore the possibilities within his field, the impact of his work is likely to resonate within the medical community and beyond.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…